江西开元生物医药科技有限公司
企业 · 新余市, China · LEI 836800LN0OXCC9GWLJ43
LEI lapsed
Summary
江西开元生物医药科技有限公司 is registered in China and entered in the “National Enterprise Credit Information Publicity System” under number 9136050406535263XB. Its legal form is 企业 – enterprise (China). According to GLEIF, its ultimate parent is 湘潭市开元化学有限公司 (China), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in China. The LEI was first issued on 24 Nov 2021 and the record was last updated on 10 May 2023. It has lapsed: renewal was due by 10 May 2024. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 10 May 2024 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 27 Mar 2023, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 10 May 2023.
Company details
| Legal form | 企业 enterprise (China) |
|---|---|
| Register | National Enterprise Credit Information Publicity System · Register website |
| Registration number | 9136050406535263XB |
| Registration authority | State Administration for Market Regulation |
| Jurisdiction | China |
| Registered address | 高新区东兴北路鲇口村, 338000 新余市, China |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 1 Jan 1900 |
| LEI | 836800LN0OXCC9GWLJ43 |
| LEI status | lapsed |
| LEI first issued | 24 Nov 2021 |
| LEI record last updated | 10 May 2023 |
| Next LEI renewal | 10 May 2024 |
| Corroboration of the LEI record | fully corroborated |
Group membership
江西开元生物医药科技有限公司 this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | 湘潭市开元化学有限公司 | 湘潭市开元化学有限公司 |
| Accounting period | 28 Mar 2013 to 27 Mar 2023 | 28 Mar 2013 to 27 Mar 2023 |
| Evidence | other official documents | other official documents |
| Corroboration | fully corroborated | fully corroborated |
| Consolidation percentage reported to GLEIF | 100.00% | 100.00% |
| Relationship start | 28 Mar 2013 | 28 Mar 2013 |
| Recorded at GLEIF since | 24 Nov 2021 | 24 Nov 2021 |
| Last updated | 10 May 2023 | 10 May 2023 |
| Record status | not renewed | not renewed |
Other names
- KAIYUAN BIOPHARMA CO., LTD. · name in another language